SOX9 is required for kidney fibrosis and regulates NAV3 to control renal myofibroblast function in mice and humans (2019)

First Author: Raza S

Attributed to: MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/838441

Publication URI: http://dx.doi.org/10.1101/838441

Type: Preprint